Stocks
Allergan (AGN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 518.5% | 777.2% | 600.2% | 894.0% | 483.2% | 487.2% | |||
| Changes by years, y/y, % | +63pp | +259pp | -177pp | +294pp | -411pp | +1.2% | |||
Allergan. R&D/CAPEX, %
Allergan. R&D/CAPEX, changes, pp
Allergan (AGN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | LTM ? | |||
| R&D/CAPEX, % | 671.3% | 514.3% | 469.8% | 370.9% | 711.9% | 487.2% | ||
| Changes by years, y/y, % | -352pp | -632pp | -254pp | -396pp | +41pp | |||
| Changes by quarters, q/q, % | -96pp | -157pp | -44pp | -99pp | +341pp | |||
